Par Pharmaceutical

Type: Company
Name: Par Pharmaceutical
First reported Jul 21 2014 - Updated Jul 21 2014 - 1 reports

7/21/14 - Par Pharmaceutical Begins Shipment of Fluphenazine Decanoate Injection, USP

By a News Reporter-Staff News Editor at Pharma Business Week Par Pharmaceutical Companies, Inc. announced that it has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for fluphenazine decanoate ... [Published Pharmacy Choice - Jul 21 2014]
First reported Jul 11 2014 - Updated Jul 11 2014 - 1 reports

FLUPHENAZINE DECANOATE Injection, Solution [Par Pharmaceutical, Inc.]

First reported Jul 09 2014 - Updated Jul 10 2014 - 3 reports

Par Pharmaceutical begins shipment of Fluphenazine Decanoate injection, USP

Par Pharmaceutical Companies has received final approval from the US Food and Drug Administration for its Abbreviated New Drug Application for fluphenazine decanoate injection, USP 25 mg/mL. ... [Published PBR - News - Jul 10 2014]
First reported Jul 07 2014 - Updated Jul 07 2014 - 1 reports

Intellipharmaceutics Announces Second Quarter 2014 Results

(GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, ... [Published Virtual Strategy Magazine - Jul 07 2014]
First reported Jul 04 2014 - Updated Jul 04 2014 - 1 reports

Court Report -- Part II

By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Otsuka Pharmaceutical Co. Ltd. v. Par Pharmaceutical Inc. 1:14-cv-00789; filed June 20, 2014 in the District Court of Delaware Infringement ... [Published Patent Docs - Jul 04 2014]
First reported Jun 15 2014 - Updated Jun 15 2014 - 1 reports

NASCOBAL (Cyanocobalamin) Spray [Par Pharmaceutical , Inc]

First reported Jun 12 2014 - Updated Jun 12 2014 - 1 reports

NASCOBAL (Cyanocobalamin) Spray [Par Pharmaceutical , Inc]

First reported May 20 2014 - Updated May 20 2014 - 1 reports

DANTRIUM (Dantrolene Sodium) Injection [Par Pharmaceutical, Inc.]

First reported May 07 2014 - Updated May 07 2014 - 1 reports

Par Pharmaceutical Announces Quarterly Conference Call

WOODCLIFF LAKE, N.J., May 7, 2014 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. announced today that it will host a conference call on Friday, May 16, 2014 at 9:30 a.m. EDT to review its results of operations for the first quarter ended March 31, ... [Published PR Newswire: Health - May 07 2014]
First reported Apr 23 2014 - Updated Apr 24 2014 - 2 reports

NIFEDIPINE EXTENDED-RELEASE (Nifedipine) Tablet, Extended Release [Par Pharmaceutical, Inc.]

First reported Apr 20 2014 - Updated Apr 20 2014 - 1 reports

FENTANYL CITRATE Lozenge [Par Pharmaceutical Inc.]

First reported Apr 08 2014 - Updated Apr 08 2014 - 1 reports

DIGOXIN Tablet [Par Pharmaceutical, Inc]

Quotes

Infringement of U S Patent Nos. 7,659,282 ( "Pharmaceutical Compositions Comprising Dextromethorphan and Quinidine for the Treatment of Neurological Disorder" issued February 9, 2010) and 8,227,484 ("Pharmaceutical Compositions Comprising Dextromethorphan and Quinidine for the Treatment of Neurological Disorder,"...
...Dr. Isa Odidi, CEO and co-founder of the Company, stated, "We believe that the number of competitors tentatively approved or in the market at this time is an indication that our drug delivery technologies and competence are robust and well-adapted to the formulation of difficult-to-replicate generic drug products."
Transparency Market Research Report adds "Generic Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2012 - 2018" to its database...
...noted the FDA approval of the company's application for a generic version of Focalin XR is a major milestone for the company in several respects. "We believe that the approval represents a strong validation of our core drug development competence and our controlled-release delivery technologies. "At the same time, we have demonstrated that we can partner with an established and well-regarded pharmaceutical company, in this case Par Pharmaceutical, to see a product through to commercialization in the United States. "Finally, this generic product will generate our first revenues from commercial sales of a drug product in the United States and provide an enhanced level of financial flexibility to the Company," Dr Odidi added. Latest News"

More Content

All (34) | News (12) | Reports (0) | Blogs (21) | Audio/Video (0) | Fact Sheets (1) | Press Releases (0)
sort by: Date | Relevance
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN Tablet... [Published DailyMed Drug Label Updates for the last seven ... - Jul 24 2014]
7/21/14 - Par Pharmaceutical Begins Shipment of... [Published Pharmacy Choice - Jul 21 2014]
FLUPHENAZINE DECANOATE Injection, Solution [Par... [Published DailyMed Drug Label Updates for the last seven ... - Jul 11 2014]
Par Pharm begins shipment of fluphenazine decan... [Published PharmaBiz - Jul 10 2014]
Par Pharmaceutical begins shipment of Fluphenaz... [Published PBR - News - Jul 10 2014]
Par Pharmaceutical Begins Shipment of Fluphenaz... [Published CEOWorld Magazine - Jul 09 2014]
Par Pharmaceutical Begins Shipment of Fluphenaz... [Published PR Newswire: Policy & Public Interest - Jul 09 2014]
Intellipharmaceutics Announces Second Quarter 2... [Published Virtual Strategy Magazine - Jul 07 2014]
Intellipharmaceutics Announces Second Quarter 2... [Published Scottrade - Jul 07 2014]
Court Report -- Part II - July 2014 [Published JD Supra - Jul 07 2014]
Court Report -- Part II [Published Patent Docs - Jul 04 2014]
June 2014: Life Sciences Litigation Update [Published JD Supra - Jul 01 2014]
Stirring the Pot of AIA Alphabet Soup: Now that... [Published FDA Law Blog - Jun 24 2014]
Mealey's IP/Tech - Delaware Federal Judge Finds... [Published Mealey - Jun 23 2014]
NASCOBAL (Cyanocobalamin) Spray [Par Pharmaceut... [Published DailyMed Drug Label Updates for the last seven ... - Jun 15 2014]
NASCOBAL (Cyanocobalamin) Spray [Par Pharmaceut... [Published DailyMed Drug Label Updates for the last seven ... - Jun 12 2014]
Ignyta taps TPG Capital’s Chacko as CFO [Published PE Hub Blog - Jun 02 2014]
DANTRIUM (Dantrolene Sodium) Injection [Par Pha... [Published DailyMed Drug Label Updates for the last seven ... - May 20 2014]
Par Pharmaceutical Announces Quarterly Conferen... [Published PR Newswire: Health - May 07 2014]
NIFEDIPINE EXTENDED-RELEASE (Nifedipine) Tablet... [Published DailyMed Drug Label Updates for the last seven ... - Apr 24 2014]
NIFEDIPINE EXTENDED-RELEASE (Nifedipine) Tablet... [Published DailyMed Drug Label Updates for the last seven ... - Apr 23 2014]
FENTANYL CITRATE Lozenge [Par Pharmaceutical Inc.] [Published DailyMed Drug Label Updates for the last seven ... - Apr 20 2014]
DIGOXIN Tablet [Par Pharmaceutical, Inc] [Published DailyMed Drug Label Updates for the last seven ... - Apr 08 2014]
Par Pharmaceutical Begins Shipment of Potassium... [Published PR Newswire: Health - Apr 07 2014]
Par Pharmaceutical Names Terrance J. Coughlin C... [Published PR Newswire: General Business - Apr 01 2014]
CIPROFLOXACIN EXTENDED-RELEASE (Ciprofloxacin) ... [Published DailyMed Drug Label Updates for the last seven ... - Mar 22 2014]
MEGACE ES (Megesterol Acetate) Suspension [Par ... [Published DailyMed Drug Label Updates for the last seven ... - Mar 22 2014]
Snowball Effect: The Incidence of Premature Par... [Published FDA Law Blog - Mar 17 2014]
Par Pharmaceutical Announces Fourth Quarter and... [Published PR Newswire: Health - Mar 13 2014]
Intellipharmaceutics Receives $3.1 Million From... [Published GlobeNewswire - Feb 03 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN Tablet... [Published DailyMed Drug Label Updates for the last seven ... - Jul 24 2014]
Updated Date: Jul 21, 2014 EST ...
FLUPHENAZINE DECANOATE Injection, Solution [Par... [Published DailyMed Drug Label Updates for the last seven ... - Jul 11 2014]
Updated Date: Jul 11, 2014 EST ...
Par Pharmaceutical begins shipment of Fluphenaz... [Published PBR - News - Jul 10 2014]
Par Pharmaceutical Companies has received final approval from the US Food and Drug Administration for its Abbreviated New Drug Application for fluphenazine decanoate injection, USP 25 mg/mL. ...
Par Pharmaceutical Begins Shipment of Fluphenaz... [Published PR Newswire: Policy & Public Interest - Jul 09 2014]
WOODCLIFF LAKE, N.J., July 9, 2014 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. today announced that it has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for fluphenazine decanoate injection, ...
Court Report -- Part II [Published Patent Docs - Jul 04 2014]
By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Otsuka Pharmaceutical Co. Ltd. v. Par Pharmaceutical Inc. 1:14-cv-00789; filed June 20, 2014 in the District Court of Delaware Infringement ...
1 2 3 4 5
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.